Investigators from Vanderbilt University Medical Center, the University of Utah, Carnegie Mellon University, the University of Virginia, and Stanford University received funding from the National Institutes of Health’s Helping to End Addiction Long-term (HEAL) initiative.
Jessica Foley, PhD, discussed focused ultrasound's potential for pain management at a conference sponsored by the Virginia Workers’ Compensation Commission.
HistoSonics hosted a workshop with the Universities of Michigan and Wisconsin where each shared their research and clinical experiences with histotripsy.
The journal Neurology published clinical outcome data indicating that essential tremor patients treated with focused ultrasound experienced sustained relief at their three-year follow-up.
HistoSonics CEO Mike Blue shares details of the company’s transformative year, including notable investments, a successful clinical trial, and expanded manufacturing of their novel, multi-application platform.